The Federal Trade Commission said Friday that it is suing three drug middlemen, accusing them of inflating insulin prices.

Cigna Group closed $14.69 short of its 52-week high ($370.83), which the company reached on September 16th.

The Federal Trade Commission (FTC) is suing pharmacy benefit managers CVS Health (CVS), Cigna Group (CI), and UnitedHealth ...

Bloomberg Washington Correspondents Joe Mathieu and Kailey Leinz deliver insight and analysis on the latest headlines from ...

The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...

The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...

The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...

The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...

On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

David Cordani, chairman and CEO of The Cigna Group, and Joshua Bolten, CEO of Business Roundtable, hosted the event and were ...

The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...